Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 6, 2008, Pages 491-499

  Lentz, Meredith ^a   Kumar, Kiran ^a  

^a Bavarian Immunology   (Germany)

Author keywords

Cytokine; Immunoadsorption; Metastatic cancer; Plasma; Soluble interleukin 2 receptor; Soluble tumor necrosis factor receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; FLU LIKE SYNDROME; HEMODIALYSIS; HUMAN; IMMUNOADSORPTION; MALE; METASTASIS; PRIORITY JOURNAL; TUMOR NECROSIS;

ADULT; AGED; CHROMATOGRAPHY, AFFINITY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; INFLAMMATION; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NECROSIS; NEOPLASM METASTASIS; PLASMA; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 58149191489     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00640.x     Document Type: Article

References (9)

1. Israel L, Edelstein R. In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality. Isr J Med Sci 1978 14 : 105 30.
2. Lentz MR. The phylogeny of oncology. Mol Biother 1990 2 : 137 44.
3. Lentz MR. The role of therapeutic apheresis in the treatment of cancer: a review. Ther Apher 1999 3 : 40 9.
4. Langkopf F, Atzpodien J. Soluble tumour necrosis factor receptors as prognostic factors in cancer patients. Lancet 1994 344 : 57 8.
5. Selinsky CL, Howell MD. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. Cell Immunol 2000 200 : 81 7.
6. Elsasser-Beile U, Gallati H, Weber W, Wild ED, Schulte Monting J, von Kleist S. Increased plasma concentrations for type I and II tumor necrosis factor receptors and IL-2 receptors in cancer patients. Tumour Biol 1994 15 : 17 24.
7. Lentz MR. Continuous whole blood ultrapheresis procedure in patients with metastatic cancer. J Biol Response Mod 1989 8 : 511 27.
8. Lentz MR, Hubbard W, Fischer C. Low molecular weight protein apheresis and regression of breast cancer. Jpn J Apher 1997 16 : 107 14.
9. Lentz MR, Saltonstahl WP. Apheresis of low molecular weight protein fraction and the onset of labor. J Clin Apher 1990 5 : 62 7.